[Therapeutic experiences with clotiazepam (Trecalmo), a new anxiolytic drug from the thienodiazepine group. Results of a field study on 186 patients].
The efficacy and the compatibility of the new anxiolytic Trecalmo (Clotiazepam) were investigated by means of a field trial covering 186 patients, suffering from anxiety and tension as well as from psychosomatic disorders. The new drug proved to be remarkably effective in symptoms as anxiety, restlessness, irritations, tension headache as well as functional cardiovascular diseases and digestive disorders. The compatibility was good.
D000328:Adult; D000818:Animals; D001381:Azepines / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001682:Biological Availability; D001711:Biotransformation; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D051381:Rats
D001381:Azepines
Therapeutische Erfahrungen mit Clotiazepam (Trecalmo), einem neuen Anxiolytikum aus der Gruppe der Thienodiazepine. Ergebnisse eines Feldversuchs bei 186 Patienten.